Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

  • ID: 2517135
  • SWOT Analysis
  • 66 pages
  • GlobalData
  • Biocon
1 of 5

FEATURED COMPANIES

  • Bharat Immunolo
  • GangaGen Inc.
  • Panacea Biotec Limited
  • MORE
Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biocon Limited (Biocon) is a global biopharmaceutical company specialized in biopharmaceuticals and research services. The company produces a wide range of active pharmaceutical ingredients (APIs), branded formulations and biologicals. Its core therapeutic areas include anti-diabetics, cardiovascular, anti-inflammatory, anti-obesity, hepato-protective and gastro-intestinal drugs, nutraceuticals, digestive-aid enzymes, immunosuppressants and anti-oxidants. The company offers branded formulations in the fields of cardiology, diabetology, oncology, immunotherapy, nephrology and comprehensive care. The company also provides licensing, contract manufacturing and research services to biotechnology and pharmaceutical companies. It delivers research and development solutions to partners and customers across the world. Biocon is headquartered in Bangalore, Karnataka, India.

Biocon Limited Key Recent Developments

Jul 21, 2016: Biocon Reports a Strong Q1 FY17 Revenues at Rs. 952 Crore, Up by 11%; EBITDA Up 15% to Rs. 271 Crore; Net Profit Up 17% at Rs. 147 Crore
Apr 26, 2016: Biocon Q4FY16 Net Profit at Rs 361 Cr Revenue Crosses Rs 1,000 Cr; Up 17%
Apr 26, 2016: Biocon : Q4FY16 Net Profit at Rs 361 Cr; Revenue Crosses Rs 1,000 Cr; Up 17%
Jan 22, 2016: Biocon Announces Q3 results for the quarter ended December 31, 2015
Jan 21, 2016: Biocon Q3FY16 Net Profit Up 13% at Rs 103 Crore, EBITDA Increases 23% to Rs 209 Crore, Revenues at Rs 857 Crore, up by 10%

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bharat Immunolo
  • GangaGen Inc.
  • Panacea Biotec Limited
  • MORE
List of Tables

List of Figures

Section 1 - About the Company

Biocon Limited - Key Facts

Biocon Limited - Key Employees

Biocon Limited - Key Employee Biographies

Biocon Limited - Major Products and Services

Biocon Limited - Pharmaceutical Pipeline Products Data

Biocon Limited, Pipeline Products by Therapy Area

Biocon Limited, Pipeline Products by Development Phase

Biocon Limited - History

Biocon Limited - Company Statement

Biocon Limited - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Biocon Limited - Business Description

Biocon Limited - Corporate Strategy

Biocon Limited - SWOT Analysis

SWOT Analysis - Overview

Biocon Limited - Strengths

Strength - Focused Research & Development

Strength - Revenue Services and Core Biopharma

Strength - Strategic Agreements and Collaborations

Biocon Limited - Weaknesses

Weakness - Increased Credit Risk

Weakness - Patent Infringement Lawsuit

Biocon Limited - Opportunities

Opportunity - Strategic Initiatives

Opportunity - Product Pipeline

Opportunity - Branded Biologics Sales to Grow

Opportunity - New Approvals and Launches

Biocon Limited - Threats

Threat - Competitive Pressures

Threat - Government Regulations

Threat - Usage of Hazardous Materials

Biocon Limited - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Biocon Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Biocon Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Biocon Limited, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 21, 2016: Biocon Reports a Strong Q1 FY17 Revenues at Rs. 952 Crore, Up by 11%; EBITDA Up 15% to Rs. 271 Crore; Net Profit Up 17% at Rs. 147 Crore

Apr 26, 2016: Biocon Q4FY16 Net Profit at Rs 361 Cr Revenue Crosses Rs 1,000 Cr; Up 17%

Apr 26, 2016: Biocon : Q4FY16 Net Profit at Rs 361 Cr; Revenue Crosses Rs 1,000 Cr; Up 17%

Jan 22, 2016: Biocon Announces Q3 results for the quarter ended December 31, 2015

Jan 21, 2016: Biocon Q3FY16 Net Profit Up 13% at Rs 103 Crore, EBITDA Increases 23% to Rs 209 Crore, Revenues at Rs 857 Crore, up by 10%

Nov 03, 2015: Biocon is the Only Asian Company to be ranked in Top 20 Global Biotech Employers for 2015

Oct 20, 2015: Biocon Q2FY16 Revenues Up 12%; Net Profit Up 200% Syngene Delivers 30% Growth

Sep 15, 2015: Biocon Inaugurates World Class Devices Facility

Aug 24, 2015: Biocon Clarifies On FDA’s Inspection

Jul 23, 2015: Biocon's Earnings Surge in Q1 FY16; Revenue up by 15% at Rs. 857 Crore, Net Profit up by 23% at Rs. 126 Crore

Section 6 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

Biocon Limited, Key Facts

Biocon Limited, Key Employees

Biocon Limited, Key Employee Biographies

Biocon Limited, Major Products and Services

Biocon Limited, Number of Pipeline Products by Therapy Area

Biocon Limited, Number of Pipeline Products by Development Stage

Biocon Limited, Pipeline Products By Therapy Area and Development Phase

Biocon Limited, History

Biocon Limited, Other Locations

Biocon Limited, Subsidiaries

Biocon Limited, Key Competitors

Biocon Limited, Ratios based on current share price

Biocon Limited, Annual Ratios

Biocon Limited, Interim Ratios

Biocon Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Biocon Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Biocon Limited, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Biocon Limited, Pipeline Products by Therapy Area

Biocon Limited, Pipeline Products by Development Phase

Biocon Limited, Performance Chart (2012 - 2016)

Biocon Limited, Ratio Charts

Biocon Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Biocon Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Sun Pharmaceutical Industries Limited
Sun Pharma Advanced Research Company Ltd.
Serum Institute of India Limited
Piramal Enterprises Limited
Panacea Biotec Limited
Morepen Laboratories Limited
GangaGen Inc.
Dr. Reddy's Laboratories Limited
Bharat Immunolo
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll